WHAT WE DO
Regulatory Strategy & Market Access Planning

    •   Strategic advice on submission pathways across UK, EU, and international markets
    •    Product classification, regulatory risk mapping, and timeline optimisation
    •    Guidance for novel therapies and emerging technologies
___________________________________________________
Dossier Compilation & Submission Support

    •    Full support with CTD/eCTD preparation and formatting
    •    End-to-end assistance for NDA, ANDA, MAA, IND, and variation filings
    •    Authoring and reviewing CMC Data, bridging data, and regulatory justifications
___________________________________________________
Regulatory Intelligence & Gap Analysis

    •    Review of existing data packages against current regulatory requirements
    •    Gap identification and mitigation strategies
    •    Ongoing updates on evolving MHRA, EMA, and ICH guidelines
___________________________________________________
Labelling & Packaging Compliance

    •    End-to-end review of labelling, SmPC, PILs, cartons, and outer packaging
    •    Compliance with QRD templates and local market adaptations
    •    Lifecycle management of labelling updates and variations
___________________________________________________
Post-Approval & Lifecycle Support

    •    Change management, post-authorisation variations, renewals
    •    CMC support for updates to manufacturing, testing, or supply chain
    •    Regulatory documentation for global supply continuity
___________________________________________________
WHO WE WORK WITH

EARLY-STAGE START-UPS AND ACADEMIC SPINOUTS
MID-SIZED BIOTECH AND PHARMA
GLOBAL PHARMACEUTICAL COMPANIES REQUIRING REGULATORY REPRESENTATION

Whether you’re submitting your first application or managing a broad portfolio, we tailor our support to your structure and scale.
Back to Top